一种遵循IEC 61850标准的合并单元同步的实现新方法

简要分析了电子式互感器和保护控制设备接口的相关国际标准，指出合并单元的设计是实现此接口的关键因素。就遵循IEC61850-9-1标准设计合并单元时所面临的同步问题，分析了需具体实现的功能，并提出了一种利用现场可编程逻辑门阵列器件解决的新方法。此方法在准确、可靠判断同步输入时钟脉冲上升沿后进行多路电流、电压同步采样，在同步输入时钟受到干扰或短时丢失时，可对其进行实时跟踪和判断，从而在输入时钟恢复正常后实现合并单元的快速同步。软件仿真和实验结果均证明了此方法的有效性。     

一种基于模糊逻辑的新型故障序分量选相元件

在对两种传统的序分量比相选相元件的动作特性进行深入分析的基础上 ,提出了一种基于模糊逻辑的新型故障序分量选相元件。该元件应用模糊逻辑思想 ,将Δ I·1/I·2 和 I·0 /I·2 两种序分量比相选相元件有机地融合在一起 ,充分发挥了序分量比相选相元件的优势。该元件能够仅通过故障相区的比较就实现故障选相 ,不需配合其他判别方法 ,也不需要用户进行整定计算。仿真结果表明 ,通过合理地设置选相判据的权重以及动作阈值 ,可以使选相结果基本不受过渡电阻和系统运行方式的影响 ,具有较强的鲁棒性     

一种序分量高压线路保护选相元件

本文通过对各种不对称故障的序分量相对相位关系的分析，得出了一种新型的序分量电流相对相位与不对称故障类型的对应关系，提出了新型的故障相区划分方法，用于高压线路保护的选相元件，能够准确确认各种故障类型及故障相别。通过大量动模试验表明，是高压线路保护实现单相重合闸较为理想的选相元件     

基于WAMS的电力系统受扰轨迹预测

基于相量测量单元（PMU）上传的实时功角数据,应用曲线拟合理论,提出了一种电力系统事故后功角轨迹快速预测的新方法。该方法从一个简单电力系统调速控制模型出发,推导出了功角与时间关系的数学模型,即功角随时间呈正弦衰减变化。由此提出了利用三角函数曲线拟合技术,对功角受扰轨迹进行预测。对IEEE 9节点系统与华北电网进行了仿真计算,结果验证了该方法的有效性。此外,与多项式曲线拟合法的对比分析表明,该方法优于传统的多项式曲线拟合法,具有更好的预测效果。     

变电站综合自动化技术发展趋势

介绍了变电站综合自动化的最新发展和主要趋势，并对计算机网络的选 用原则、子站的设计等问题进行了讨论，最后概括了综合自动化系统的主要优点     

Optimal ordering decision for deteriorating items with expiration date and uncertain lead time

The ordering policy for the retailers and the suppliers is a function of deterioration, product expiration date, the supplier’s uncertain lead time, available capital constraint and the retailer’s seasonal pattern demand. We develop a deteriorating inventory replenishment model of the system and present an algorithm to derive the retailer’s optimal replenishment cycle, shortage period, order quantity and the supplier’s managing cost. Numerical example and sensitivity analysis are given to illustrate the model.     

神经网络在汽车起重机幅度预测中的应用及泛化性能分析

探讨了BP神经网络和广义回归神经网络在汽车起重机幅度预测中的应用方法,结合实测数据对比了不同神经网络结构的计算精度和泛化性能差异;为了弥补神经网络算法外推性能较差的缺点,结合工程应用实际,提出了一种通过降维拟合外推超载工况样本数据,从而提高基于神经网络的幅度预测算法泛化性能的方法.     

Enhancement of CD8+ T-Cell-Mediated Tumor Immunotherapy via Magnetic Hyperthermia

Magnetic hyperthermia (MHT) uses magnetic iron oxide nanoparticles (MIONs) to irradiate heat when subjected to an alternating magnetic field (AMF), which then trigger a series of biological effects to realize rapid tumor-killing effects. With the deepening in research, MHT has also shown significant potential in achieving antitumor immunity. On the other hand, immunotherapy in cancer treatment has gained increasing attention over recent years and excellent results have generally been reported. Using MHT to activate antitumor immunity and clarifying its synergistic mechanism, i. e., immunogenic cell death (ICD) and immunosuppressive tumor microenvironment (TME) reversal, can achieve a synergistically enhanced therapeutic effect on primary tumors and metastatic lesions, and this can prevent cancer recurrence and metastasis, which thus prolong survival. In this review, we discussed the role of MHT when utilized alone and combining MHT with other treatments (such as radiotherapy, photodynamic therapy, and immune checkpoint blockers) in the process of tumor immunotherapy, including antigen release, dendritic cells (DCs) maturation, and activation of CD8⁺ cytotoxic T lymphocytes. Finally, the challenges and future development of current MHT and immunotherapy are discussed.     

Accurately Detecting Trace-Level Infectious Agents by an Electro-Enhanced Graphene Transistor

For epidemic prevention and control, molecular diagnostic techniques such as field-effect transistor (FET) biosensors is developed for rapid screening of infectious agents, including Mycobacterium tuberculosis, SARS-CoV-2, rhinovirus, and others. They obtain results within a few minutes but exhibit diminished sensitivity (<75%) in unprocessed biological samples due to insufficient recognition of low-abundance analytes. Here, an electro-enhanced strategy is developed for the precise detection of trace-level infectious agents by liquid-gate graphene field-effect transistors (LG-GFETs). The applied gate bias preconcentrates analytes electrostatically at the sensing interface, contributing to a 10-fold signal enhancement and a limit of detection down to 5 × 10⁻¹⁶ g mL⁻¹ MPT64 protein in serum. Of 402 participants, sensitivity in tuberculosis, COVID-19 and human rhinovirus assays reached 97.3% (181 of 186), and specificity is 98.6% (213 of 216) with a response time of <60 s. This study solves a long-standing dilemma that response speed and result accuracy of molecular diagnostics undergo trade-offs in unprocessed biological samples, holding unique promise in high-quality and population-wide screening of infectious diseases.